Roche To Pay Chiron $78M To Settle Patent Dispute
Swiss drug maker F. Hoffmann-La Roche will pay U.S. biotech company Chiron Corp. $78 million to settle a dispute over licensing fees and royalties related to nucleic acid testing methods for...To view the full article, register now.
Already a subscriber? Click here to view full article